首页> 外文期刊>Acta Radiologica >Sentinel node detection in melanomas using contrast-enhanced ultrasound.
【24h】

Sentinel node detection in melanomas using contrast-enhanced ultrasound.

机译:黑色素瘤中使用对比增强超声的前哨淋巴结检测。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: Sentinel node (SN) biopsy has proven to be a useful clinical method based on the combination of radionuclide tracer principles and the dye technique. Contrast-enhanced ultrasound (CEUS) has been used successfully for detection of SN in animals, but the use of CEUS has not been reported in humans. PURPOSE: To investigate the possible use of CEUS in detecting SN in patients with malignant melanomas (MM), and to improve the method by using different concentrations of contrast agent and various positions of the extremity. MATERIAL AND METHODS: Ten patients with MM on an extremity and one healthy volunteer were included. One milliliter of a contrast agent (Sonovue; Bracco, Milan, Italy) was injected subcutaneously on both sides of the scar from the excised tumor. Contrast-enhanced lymph channels and lymph nodes (LNs) were searched for using low-mechanical-index CEUS and by stimulated acoustic emission. Afterward, lymphoscintigraphy was performed and the patient operated. During surgery, the SNs were located via scintigraphic findings, gamma-probe signals, and blue-dye visualization of lymph channels and LNs. Before the human study, a study of 10 mice was performed to exclude possible tissue damage, as the contrast agent was not registered for subcutaneous administration. RESULTS: In one patient, two contrast-enhanced inguinal LNs were visualized by CEUS, corresponding to two inguinal SNs found by scintigraphic imaging. No contrast-enhanced lymph channels or LNs were visualized in any other patients or in the volunteer. No tissue damage was observed in the 10 mice. CONCLUSION: This study does not support the use of CEUS for detection of SNs in humans. However, the application of CEUS for the investigation of SNs is still not fully explored in humans, and an alternative setup and/or contrast agent might provide better results.
机译:背景:前哨淋巴结活检已被证明是结合放射性核素示踪原理和染料技术的一种有用的临床方法。对比增强超声(CEUS)已成功用于动物中SN的检测,但尚未在人类中报道使用CEUS。目的:探讨CEUS在恶性黑色素瘤(MM)患者中检测SN的可能用途,并通过使用不同浓度的造影剂和肢体的不同位置来改进该方法。材料与方法:包括十名四肢MM患者和一名健康志愿者。在切除的肿瘤的疤痕两侧皮下注射一毫升的对比剂(Sonovue; Bracco,米兰,意大利)。使用低机械指数CEUS和受激声发射来搜索增强造影剂的淋巴通道和淋巴结(LN)。之后,进行了淋巴闪烁成像术,并对患者进行了手术。在手术过程中,通过闪烁显像,伽玛探针信号以及淋巴通道和LN的蓝染料可视化来定位SN。在进行人体研究之前,对10只小鼠进行了研究,以排除可能的组织损伤,因为造影剂未注册用于皮下给药。结果:在一名患者中,CEUS可视化了两个对比增强的腹股沟腹股沟淋巴结,对应于通过闪烁显像发现的两个腹股沟SN。在其他任何患者或志愿者中均未观察到造影剂增强的淋巴通道或LN。在10只小鼠中未观察到组织损伤。结论:本研究不支持使用CEUS检测人类的SN。但是,CEUS在SN的研究中的应用仍未在人类中得到充分探索,并且替代设置和/或造影剂可能会提供更好的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号